3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
4
Rectal Neoplasms
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Hypoxia
1
Gynecologic Cancer
1
Fallopian Tube Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Interventions
Carboplatin
15
Paclitaxel
13
Hyperthermic Intraperitoneal Chemotherapy
6
Cisplatin
5
olaparib
4
niraparib
4
Bevacizumab
4
oregovomab
3
Topotecan
3
Immunohistochemistry
3
Gemcitabine
3
Drug Therapy
3
Docetaxel
3
Cyclophosphamide
3
Chemotherapy, Adjuvant
3
Amplified Fragment Length Polymorphism Analysis
3
pembrolizumab
2
liposomal doxorubicin
2
anlotinib
2
ST 1481
2
Radiotherapy
2
Polymerase Chain Reaction
2
Oxaliplatin
2
Neoadjuvant Therapy
2
Gene Expression Profiling
2
Fluorouracil
2
Flow Cytometry
2
Diathermy
2
Cytoreduction Surgical Procedures
2
Blood Specimen Collection
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Carcinoma, Ovarian Epithelial
×
Diagnostic Imaging
×
Clear all
NCT04001023
2019-08-07
OVANOX
Turku University Hospital
Phase NA
Unknown
40 enrolled